TrialESMO open2026

Efficacy and safety of trastuzumab emtansine in patients with advanced human epidermal growth factor receptor 2-positive extramammary Paget's disease: an investigator-initiated, open-label, single-arm, multicentre, prospective, phase II clinical trial (TEMENOS-2).

S Arakawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.